Want to join the conversation?
$SRCL said that YTD as reported cash from operations was $390MM. In the quarter the company closed 10 acquisitions; 6 domestic and 4 international. Looking ahead, the company is seeing growth opportunities and for 2016, $SRCL is expecting analyst EPS estimate in the range of $5.26-5.33 and revenue estimate in the $3.6-3.67Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?